Yana Kipnis
Lawyers
Filters
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Marvell Technology $1 billion senior notes offering
The senior notes are due 2029 and 2033
Intuit $4 billion notes offering
The investment-grade offering comprises four tranches of notes
PracticeTek merger with Integrated Practice Solutions and related financing
We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Natura $2.525 billion sale of Aesop to L’Oréal
We are advising Natura on the transaction